CASTLE BIOSCIENCES, INC.
Last · NASDAQ$33.11+0.23 (+0.70%)close · yahoo · 15h ago
Vol 243.2K ≈ 8.05M
MA10MA20MA50
Market cap$1.01B30.5M sh
P/E · TTM-50.9fwd -36.3 · eps -0.65 · loss
Beta0.94vs S&P 500
Div yield0.00%annual · TTM
52w range
$17.72$44.28
Volume243.2Ksession
Issuer
Legal nameCASTLE BIOSCIENCES, INC.
HQUnited States (US)
ListingUS CSTL
ISINUS14843C1053
SectorHealthcare
IndustryHealthcare Support Services
SIC8071
CurrencyUSD
Entity registrysec:0001447362
CIK0001447362
Websitewww.castlebiosciences.com
Employees942
AddressCastle Biosciences, Inc. 1500 West Parkwood Avenue 77546, Friendswood +866 788 9007
| Revenue | $344.2M |
|---|---|
| Operating income | $-42.8M |
| Net income | $-24.2M |
| Free cash flow | $28.3M |
| Operating margin | -12.4% |
| Net margin | -7.0% |
| Return on equity | -5.1% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-02-26
From latest 10-K · 2026-02-26
- Net Margin Sharply Negative
Red flags
- Net Margin Sharply Negative — Net margin -7.0%
Upcoming earnings
MON.2NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.35
Est. revenue
92.5M
Earnings transcripts
Press & signals
- Satelight
Twenty Years of RISC OS Open